BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27905039)

  • 1. Morphogenesis of Experimental Infection Caused by Plasmid Variants of Yersinia pseudotuberculosis.
    Somova LM; Drobot EI; Plekhova NG; Lyapun IN; Shubin FN
    Bull Exp Biol Med; 2016 Dec; 162(2):264-268. PubMed ID: 27905039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioluminescent tracing of a Yersinia pestis pCD1
    Zhou Y; Zhou J; Ji Y; Li L; Tan Y; Tian G; Yang R; Wang X
    Microbes Infect; 2018 Mar; 20(3):166-175. PubMed ID: 29180033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Yersinia L-transformation in experimental pseudotuberculosis].
    Isachkova LM; Zhavoronkova AA; Shubin FN
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):11-6. PubMed ID: 8067064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes.
    Crimmins GT; Mohammadi S; Green ER; Bergman MA; Isberg RR; Mecsas J
    PLoS Pathog; 2012; 8(8):e1002828. PubMed ID: 22876175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective innate cell response and lymph node infiltration specify Yersinia pestis infection.
    Guinet F; Avé P; Jones L; Huerre M; Carniel E
    PLoS One; 2008 Feb; 3(2):e1688. PubMed ID: 18301765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complete genome sequence of Yersinia pseudotuberculosis IP31758, the causative agent of Far East scarlet-like fever.
    Eppinger M; Rosovitz MJ; Fricke WF; Rasko DA; Kokorina G; Fayolle C; Lindler LE; Carniel E; Ravel J
    PLoS Genet; 2007 Aug; 3(8):e142. PubMed ID: 17784789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alternative localization of the determinant of pathogenicity coded by the Yersinia pseudotuberculosis pVM82 plasmid].
    Shovadaeva GA; Shubin FN; Shaginian IA; Markov AP; Gintsburg AL; Smirnov GB
    Mol Gen Mikrobiol Virusol; 1991 Nov; (11):23-7. PubMed ID: 1808508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small RNA chaperone Hfq is required for the virulence of Yersinia pseudotuberculosis.
    Schiano CA; Bellows LE; Lathem WW
    Infect Immun; 2010 May; 78(5):2034-44. PubMed ID: 20231416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of yersiniosis in Egyptian rousette bats (Rousettus aegyptiacus) caused by Yersinia pseudotuberculosis serotype 4b.
    Nakamura S; Settai S; Hayashidani H; Urabe T; Namai S; Une Y
    J Comp Pathol; 2013 May; 148(4):410-3. PubMed ID: 22980777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
    McPhee JB; Mena P; Zhang Y; Bliska JB
    Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute mesenteric lymphadenitis due to Yersinia pseudotuberculosis lacking a virulence plasmid.
    Fukushima H; Sato T; Nagasako R; Takeda I
    J Clin Microbiol; 1991 Jun; 29(6):1271-5. PubMed ID: 1864948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PLASMID-ASSOCIATED VIRULENCE OF YERSINIA PSEUDOTUBERCULOSIS AND INFECTIOUS PROCESS].
    Somova LM; Shubin FN; Drobot EI; Plekhova NG; Lyapun IN
    Zh Mikrobiol Epidemiol Immunobiol; 2016 Nov; (6):74-85. PubMed ID: 30695393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence.
    Grabenstein JP; Marceau M; Pujol C; Simonet M; Bliska JB
    Infect Immun; 2004 Sep; 72(9):4973-84. PubMed ID: 15321989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of phagocytosis of Yersinia pseudotuberculosis with various sets of plasmids].
    Dubrovina VI; Golubinskiĭ EP; Borsuk GI; Balakhonov SV; Konovalova ZhA
    Med Parazitol (Mosk); 1999; (4):50-3. PubMed ID: 11221008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The new views to pseudotuberculosis pathology].
    Somova LM; Plekhova NG; Drobot EI
    Arkh Patol; 2012; 74(3):60-4. PubMed ID: 22937584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IscR is essential for yersinia pseudotuberculosis type III secretion and virulence.
    Miller HK; Kwuan L; Schwiesow L; Bernick DL; Mettert E; Ramirez HA; Ragle JM; Chan PP; Kiley PJ; Lowe TM; Auerbuch V
    PLoS Pathog; 2014 Jun; 10(6):e1004194. PubMed ID: 24945271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of O-antigen inactivation on Pla activity and virulence of Yersinia pseudotuberculosis harbouring the pPla plasmid.
    Pouillot F; Derbise A; Kukkonen M; Foulon J; Korhonen TK; Carniel E
    Microbiology (Reading); 2005 Nov; 151(Pt 11):3759-3768. PubMed ID: 16272397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic study of plasmid pVM82 which contributes to the pathogenicity of the pseudotuberculosis pathogen].
    Il'ina TS; Fil'kova SL
    Genetika; 1995 Jul; 31(7):877-82. PubMed ID: 7590200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new pathogenic trait encoded by Yersinia pseudotuberculosis pVM82 plasmid].
    Gintsburg AL; Shubin FN; Shovadaeva GA; Kulichenko AN; Ianishevskiĭ NV
    Genetika; 1988 Sep; 24(9):1562-71. PubMed ID: 3197962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The plasmid composition and pathogenetic characteristics of Yersinia pseudotuberculosis strains isolated from human subjects against a background of epidemic and sporadic morbidity].
    Brikman VD; Balakhonov SV; Mironova LP; Aparin GP
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):3-7. PubMed ID: 2683522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.